Therapeutic Delivery – Products

First-ever study in man with a vaccine candidate based on Mimopath™, a proprietary platform technology for developing more potent vaccines.

Final and complete results from the study are expected to be presented in 2011.

MJR PharmJet reckons improved efficacy and reduced side-effects of approved and new drugs.

Malvern’s Zetasizer Nano proves to be the perfect instrument for a student environment.

InVitria’s recombinant human transferrin production technology shown to be significantly more cost-effective compared to alternatives.

Dolomite has introduced a new range of Small Droplet Chips, glass microfluidic devices which can be used with the Droplet Advanced System to generate highly monodispersed micro-droplets.

Glass microfluidic devices used with the Droplet Advanced System to generate highly monodispersed micro-droplets.

Data support clinical studies in bone cancer planned for 2011.

Norton Scientific, responding to the needs of the global research community, is proud to announce that the company has launched a new applications support service targeting the field of proteomics.

U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.